English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 855454      Online Users : 1124
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/9998


    Title: Estimating impacts of asbestos-related malignant mesothelioma: Quantification of life expectancy lost and lifetime healthcare expenditures in Taiwan
    Authors: Lee, LJH;Takahashi, K;Chang, YY;Wang, JD
    Contributors: National Institute of Environmental Health Sciences
    Abstract: Malignant mesothelioma (MM) can be considered as a marker malignancy related to previous asbestos exposure. This study determines the impact of MM using average life years lost and lifetime healthcare expenditures in Taiwan. We collected patients diagnosed with pleural MM (ICD-O 163) and peritoneal MM (ICD-O 158) during 1998-2009 with histological evidence from the Taiwan Cancer Registry (TCR), which were inter-linked with the National Mortality Registry (NMR) and the National Health Insurance (NHI) reimbursement database up to 2011 to estimate survival and lifetime direct medical costs. For each MM patient, we simulated age- and gender-matched referents based on the vital statistics of Taiwan to estimate expected years of life lost (EYLL). We extrapolated lifetime survival function by a semi-parametric method after 14 years of follow-up. The mean monthly direct medical costs were calculated, multiplied with the corresponding survival probability, and summed up throughout life for the lifetime healthcare expenditures (LTHE) after adjustment for annual discount rate of 3%. A total of 300 cases of pleural MM, and 106 cases of peritoneal MM were identified in the TCR during 1998-2009. The average EYLL for pleural and peritoneal MM was 18.2 (95% confidence interval [CI]: 17.9-18.4), and 19.1 (95% CI: 18.5-19.8) years, respectively. Estimated LTHE with a 3% annual discount was $ USD 29,400 (95% CI: 24,200-33,000) for pleural MM and 27,200 (95% CI 20,500-32,000) for peritoneal MM. As MM has been under-diagnosed in Taiwan, such estimates provide lower bounds for potential saving of society on total ban of asbestos.
    Date: 2016-09
    Relation: Asbestos: Risk Assessment, Health Implications and Impacts on the Environment. 2016 Sep:83-97.
    Link to: https://www.novapublishers.com/catalog/product_info.php?products_id=58720&osCsid=
    Appears in Collections:[李俊賢] 圖書

    Files in This Item:

    File Description SizeFormat
    NEM2016100401.pdf911KbAdobe PDF350View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback